Levi & Korsinsky, LLP filed a class action lawsuit against GRAIL, Inc. for allegedly misleading investors about the NHS-Galleri cancer screening trial results. The complaint claims GRAIL made overly positive statements while concealing that the trial failed to show a significant reduction in late-stage cancers within the trial period. After GRAIL announced the primary endpoint was not met, its stock price plunged over 50% in one day. Investors who bought GRAIL stock between May 2025 and February 2026 have until August 4, 2026, to join the lawsuit as lead plaintiffs.
Lululemon invested in Syntetica's $30 million Series A funding to support its innovative recycling of Nylon 6 and Nylon 6,6, materials difficult to separate and reuse in textile waste. This move aligns with growing industry demand for sustainable, co...
Ethereum futures long positions among top traders increased by over 3 percentage points across both USDT- and coin-margined markets, indicating a broad-based shift in short-term sentiment. This rise suggests heightened attention on ETH compared to ot...
NVIDIA announced that leading Japanese companies in robotics and manufacturing are adopting its Cosmos, Isaac, Metropolis, and Jetson platforms to accelerate AI-powered intelligent machines across industries. The new Cosmos 3 Edge model enables real-...
Oil prices are rising sharply due to renewed US naval blockades on Iranian shipping and increased tensions in the Strait of Hormuz, a critical oil transit route. Brent crude is holding above $85 and WTI above $80, with forecasts suggesting WTI could ...
The US government announced it will impose a new 25% tariff on Brazilian ethanol starting next Wednesday, accusing Brazil of unfair trade practices. This tariff excludes major Brazilian exports like oil, beef, coffee, and aircraft parts. The move fol...
